廣告
香港股市 已收市
  • 恒指

    16,224.14
    -161.73 (-0.99%)
     
  • 國指

    5,746.61
    -57.25 (-0.99%)
     
  • 上證綜指

    3,065.26
    -8.96 (-0.29%)
     
  • 滬深300

    3,541.66
    -28.14 (-0.79%)
     
  • 美元

    7.8321
    +0.0009 (+0.01%)
     
  • 人民幣

    0.9239
    +0.0002 (+0.02%)
     
  • 道指

    37,986.40
    +211.02 (+0.56%)
     
  • 標普 500

    4,967.23
    -43.89 (-0.88%)
     
  • 納指

    15,282.01
    -319.49 (-2.05%)
     
  • 日圓

    0.0504
    +0.0000 (+0.02%)
     
  • 歐元

    8.3421
    +0.0077 (+0.09%)
     
  • 英鎊

    9.6890
    -0.0500 (-0.51%)
     
  • 紐約期油

    83.24
    +0.51 (+0.62%)
     
  • 金價

    2,406.70
    +8.70 (+0.36%)
     
  • Bitcoin

    64,079.40
    +1,431.05 (+2.28%)
     
  • CMC Crypto 200

    1,371.97
    +59.34 (+4.52%)
     

54 Biggest Movers From Friday

Gainers

  • Biomerica, Inc. (NASDAQ: BMRA) shares surged 38% to close at $6.21 on Friday. Biomerica entered into a Supplier Agreement with Walmart to sell its EZ Detect colorectal disease screening test within the Walmart retail system.

  • Exscientia Limited (NASDAQ: EXAI) rose 23.2% to settle at $27.10 after the company priced its IPO at $22 per ADS.

  • First Watch Restaurant Group, Inc. (NASDAQ: FWRG) gained 22.9% to close at $22.13 after pricing its IPO at $18 a share.

  • Atea Pharmaceuticals, Inc. (NASDAQ: AVIR) rose 19.8% to close at $42.01 following data from Merck & Co's investigational oral antiviral molnupiravir, which boosted sentiment for Atea Pharmaceutical's AT-527, an oral antiviral drug candidate.

  • ENGlobal Corporation (NASDAQ: ENG) surged 19.1% to settle at $3.18.

  • Vicinity Motor Corp.(NASDAQ: VEV) gained 18.7% to settle at $5.90. Vicinity Motor partnered with Aereus Technologies to offer its CuVerro Shield technology, an antimicrobial treatment option for high-touch areas of Vicinity vehicles.

  • Bitfarms Ltd (NASDAQ: BITF) climbed 18.4% to close at $5.03 amid an increase in the price of Bitcoin and Ethereum.

  • Progenity, Inc. (NASDAQ: PROG) rose 17.8% to settle at $1.79 on Friday after jumping over 40% on Thursday.

  • Silverback Therapeutics, Inc. (NASDAQ: SBTX) jumped 16.9% to close at $11.67.

  • Quotient Limited (NASDAQ: QTNT) surged 16.2% to settle at $2.72. Quotient reported commencement of review process of expanded immunohematology technical file dossier by European Notified Body.

  • Global Blue Group Holding AG (NYSE: GB) gained 16.1% to close at $7.50.

  • Liberty TripAdvisor Holdings, Inc. (NASDAQ: LTRPA) surged 15.8% to close at $3.58.

  • LSB Industries, Inc. (NYSE: LXU) gained 14.9% to close at $11.73.

  • Broadwind, Inc. (NASDAQ: BWEN) jumped 14.7% to settle at $2.97.

  • Ramaco Resources, Inc. (NASDAQ: METC) rose 14.1% to close at $14.04.

  • Wheels Up Experience Inc. (NYSE: UP) gained 14% to settle at $7.51. Credit Suisse analyst Stephen Ju initiated Wheels Up Experience with an Outperform rating and a price target of $14.

  • StarTek, Inc. (NYSE: SRT) surged 13.4% to close at $6.25.

  • Navios Maritime Holdings Inc. (NYSE: NM) gained 13% to settle at $5.39.

  • Triumph Group, Inc. (NYSE: TGI) surged 12.5% to close at $20.95. Triumph Group’s Triumph Product Support site in Grand Prairie, Texas, recently extended a repair management agreement with MTU Maintenance as a repair services supplier for engine accessories and line replacement units (LRUs) applicable to the V2500, CFM56, CF6, and CF34 engine platforms.

  • Sono-Tek Corporation (NASDAQ: SOTK) gained 12.1% to close at $4.5950.

  • Luby's, Inc. (NYSE: LUB) climbed 11.2% to close at $4.65.

  • SunPower Corporation (NASDAQ: SPWR) gained 9.7% to close at $24.87. SunPower will replace Cimarex Energy in the S&P MidCap 400 effective on Tuesday, October 5.

  • Salem Media Group, Inc. (NASDAQ: SALM) gained 9.2% to close at $4.05.

  • Merck & Co., Inc. (NYSE: MRK) gained 8.4% to settle at $81.40 after the company and Ridgeback announced investigational oral antiviral molnupiravir reduced risk of hospitalization or death by about 50% versus the placebo for patients with mild to moderate COVID-19 in Phase 3 interim analysis.

  • QuickLogic Corporation (NASDAQ: QUIK) gained 8.2% to settle at $5.80. QuickLogic reported a strategic investment by current shareholders. The company said it expects Q3 revenue of $3.8 million to $3.9 million.

  • Iterum Therapeutics plc (NASDAQ: ITRM) rose 7.7% to close at $0.6011 after dropping over 8% on Thursday.

Check out these big penny stock gainers and losers

廣告

Losers

  • Spire Global, Inc.. (NYSE: SPIR) shares fell 43.3% to close at $7.10 on Friday. Spire Global, Inc. recently appointed Dr. Kevin Petty as Vice President of Weather.

  • Omeros Corporation (NASDAQ: OMER) shares dipped 38.1% to close at $8.54 on Friday after the company announced the FDA notified it that they identified deficiencies that preclude discussion of labeling and post-marketing requirements/commitments at this time.

  • Adagio Therapeutics, Inc. (NASDAQ: ADGI) dropped 33.8% to close at $27.98. Adagio Therapeutics recently announced new data from its COVID-19 antibody program.

  • NeuroBo Pharmaceuticals, Inc. (NASDAQ: NRBO) fell 32.8% to close at $2.50 after the company announced a 4.3 million share offering at $3.25 per share.

  • Farmmi, Inc. (NASDAQ: FAMI) fell 23.6% to close at $0.3536. Farmmi recently agreed to acquire all the shares of Jiangxi Xiangbo Agriculture and Forestry Development Co., Ltd (Xiangbo) for about RMB70 million.

  • Vir Biotechnology, Inc. (NASDAQ: VIR) dropped 21.1% to close at $34.35 in reaction to promising data from competitor Merck's COVID-19 antiviral candidate.

  • Clarus Therapeutics Holdings, Inc. (NASDAQ: CRXT) dropped 19.3% to settle at $4.30. Clarus Therapeutics filed for offer and sale of up to 19.82 million shares of common stock by selling stockholders.

  • Grom Social Enterprises, Inc. (NASDAQ: GROM) fell 18.3% to close at $3.27.

  • Lordstown Motors Corp. (NASDAQ: RIDE) shares fell 18.2% to close at $6.53. Lordstown Motors issued production and financial update. Foxconn will purchase $50 million of Lordstown common stock at price of $6.8983 per share.

  • IronNet, Inc.. (NASDAQ: IRNT) shares fell 17.4% to settle at $14.08 after dropping 15% on Thursday.

  • Immunome, Inc. (NASDAQ: IMNM) fell 17.2% to settle at $20.16. Immunome will present preclinical data on anti IL-38 antibody program at The American Association for Cancer Research NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics.

  • IRSA Propiedades Comerciales S.A. (NASDAQ: IRCP) dropped 15.3% to close at $2.50.

  • Benson Hill Inc. (NASDAQ: BHIL) fell 15.2% to close at $6.05.

  • Camber Energy, Inc. (NYSE: CEI) shares declined 14.9% to settle at $3.25 after gaining over 11% on Thursday.

  • CureVac N.V. (NASDAQ: CVAC) fell 14.7% to close at $46.57 in reaction to positive data from Merck's oral antiviral molnupiravir, which reduced risk of hospitalization or death by roughly 50%.

  • Guardant Health, Inc. (NASDAQ: GH) dropped 14% to settle at $107.51 following a Bloomberg report suggesting the company is exploring an acquisition of NeoGenomics.

  • Superior Drilling Products, Inc. (NYSE: SDPI) shares declined 13.1% to close at $1.52 after jumping 60% on Thursday.

  • DatChat, Inc. (NASDAQ: DATS) dropped 12.6% to close at $11.93.

  • Novavax, Inc. (NASDAQ: NVAX) fell 12.4% to close at $181.60 in reaction to positive data from Merck's oral antiviral molnupiravir, which reduced risk of hospitalization or death by roughly 50%.

  • Dynavax Technologies Corporation (NASDAQ: DVAX) declined 12.3% to close at $16.84 on Friday.

  • Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI) fell 11.8% to settle at $43.27.

  • IonQ, Inc. (NYSE: IONQ) dipped 11.5% to close at $9.20.

  • Moderna, Inc. (NASDAQ: MRNA) dropped 11.4% to close at $341.09 in reaction to positive data from Merck's oral antiviral molnupiravir, which reduced risk of hospitalization or death by roughly 50%. Stephane Bancel, Chief Executive Officer at Moderna, made a large insider sell on September 30, according to a new SEC filing.

  • Valens Semiconductor Ltd. (NYSE: VLN) fell 11% to settle at $6.59.

  • Lyell Immunopharma, Inc. (NASDAQ: LYEL) dipped 10.2% to close at $13.29.

  • Lucira Health, Inc. (NASDAQ: LHDX) dropped 9.3% to close at $6.89. Lucira Health recently appointed Tony Allen as COO.

  • BioNTech SE (NASDAQ: BNTX) fell 6.7% to close at $254.79 in reaction to positive data from Merck's oral antiviral molnupiravir, which reduced risk of hospitalization or death by roughly 50%. BioNTech dosed the first patient with its individualized mRNA cancer vaccine BNT122 (autogene cevumeran, RO7198457) in Phase 2 clinical trial.

  • Alzamend Neuro, Inc. (NASDAQ: ALZN) fell 6.5% to close at $2.88. Ascendiant Capital analyst Edward Woo initiated coverage on Alzamend Neuro with a Buy rating and announced price target of $8.

See more from Benzinga

© 2021 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.